Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > LATEST
LATEST
-
REGULATORY Japan Panel to Review Brinsupri, Hyrnuo, Inlexzo, GSK’s Hep B Med on July 27
July 14, 2026
-
REGULATORY JPA’s Watanabe Joins Chuikyo as Healthcare Provider Rep
July 9, 2026
-
BUSINESS Fycompa Generics Head for Summer Launch as Key Patent Expires
June 23, 2026
-
REGULATORY Carvykti Earlier Use Up for Japan Panel Review on June 29
June 23, 2026
-
REGULATORY Kampo Industry Calls for Predictable Drug Pricing to Support Stable Supply
June 23, 2026
-
BUSINESS ASKA’s Relugolix Combo Hits Primary Goal in Japan PIII Fibroid Study
June 23, 2026
-
BUSINESS Rege Nephro Raises 1.22 Billion Yen to Advance ADPKD Drug, iPSC Kidney Program
June 23, 2026
-
BUSINESS Japan OTC Drug Market Falls for Third Straight Month in May: Intage
June 23, 2026
-
REGULATORY Yoshida Pharma Plant Hit with Improvement Order over Testing Violations
June 23, 2026
-
BUSINESS Lilly Japan Names Karla Alcazar as New President
June 22, 2026
-
ORGANIZATION Boehringer’s Hasson Appointed EFPIA Japan Vice Chair
June 22, 2026
-
REGULATORY Japan Approves Wegovy MASH Use, AstraZeneca’s Etcamah, Others
June 22, 2026
-
REGULATORY Japan on Alert over US MFN Drug Pricing Policy: Health Minister
June 22, 2026
-
REGULATORY Japan Restarts Deliberations on Routine Mumps Vaccination, Eyes FY2027 Rollout
June 22, 2026
-
ORGANIZATION Think Tank Opposes Cap on Social Security Burden Ratio, Urges Pause in Off-Year Price Cuts
June 22, 2026
-
REGULATORY LDP Group Calls for Pediatric Cancer Drug Development Platform
June 22, 2026
-
REGULATORY LDP Group Seeks Better Access to Advanced Eczema Care
June 22, 2026
-
REGULATORY Japan Panel Backs Revaccination after Allogeneic Stem Cell Transplantation
June 22, 2026
-
BUSINESS Shionogi’s CEO Pay Up at 302 Million Yen in FY2025
June 22, 2026
-
BUSINESS J-TEC Sets Up German Unit to Expand LabCyte Biz in Europe
June 22, 2026
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…